A Clinical Trial Agreement (CTA) is a legal contract between a sponsor and a research institution or investigator that defines the terms for conducting a clinical study.
CTAs specify roles, payments, confidentiality, intellectual property, publication rights, and liability provisions. Executed CTAs are typically required before study activation and site initiation. Well-structured agreements reduce legal and operational risk while supporting efficient startup. They also reinforce compliance expectations for ethical and regulatory trial conduct.